Pharmsville Co. Ltd. (318010) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pharmsville Co. Ltd. (318010:KRX), powered by AI.

Current Price
₩3,560
P/E Ratio
9.8
Market Cap
28.2B
Sector
Healthcare
What is the Pharmsville Co. Ltd. stock price forecast?

Pharmsville Co. Ltd. is currently trading at ₩3,560. View real-time AI analysis on Alpha Lenz.

What is Pharmsville Co. Ltd. insider trading activity?

View the latest insider trading data for Pharmsville Co. Ltd. on Alpha Lenz.

What is Pharmsville Co. Ltd.'s P/E ratio?

Pharmsville Co. Ltd.'s P/E ratio is 9.8.

Pharmsville Co. Ltd.

KRX · 318010
₩3,560+30(+0.85%)Market closedKRX regular session 09:00–15:30 KST
Ask about Pharmsville Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Pharmsville Co. Ltd. trades at a P/E of 9.8 (undervalued) with modest ROE of 4.4%.

Ask for details

Company Overview

Pharmsville Co. Ltd. is a pharmaceutical company dedicated to the research, development, manufacturing, and distribution of medical drugs and therapies. As an integral player in the healthcare sector, Pharmsville focuses on creating medications that address a wide range of medical needs, including chronic illnesses and rare diseases. The company's portfolio includes prescription drugs, over-the-counter products, and biotechnology solutions, catering to both healthcare professionals and consumers. Its research and development initiatives are fueled by state-of-the-art laboratories and collaborations with medical institutions, aiming to bring innovative and effective treatments to the market. Pharmsville Co. Ltd. plays a crucial role in the pharmaceutical industry by contributing to the advancement of medical science and enhancing patient care. Its operations significantly impact public health, influencing drug availability, accessibility, and affordability across various regions. With a commitment to quality and compliance, Pharmsville remains a pivotal entity in shaping the future of healthcare worldwide.

CEO이병욱
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees27

Company Statistics

FY 2025

Profile

₩28,228,443,280Market Cap
₩12,728,245,930Revenue
7.93MShares Out
27Employees

Margins

63.31%Gross
11.27%EBITDA
-5.29%Operating
28.21%Pre-Tax
22.80%Net

Valuation

9.77P/E
0.42P/B
2.22EV/Sales
18.61EV/EBITDA
15.48P/FCF

Growth (CAGR)

-21.30%Rev 3Yr
-20.23%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
-10.61%Net Inc 3Yr
0.23%Net Inc 5Yr

Returns

4.28%ROA
4.41%ROE
5.30%ROIC

Financial Health

₩1,673,190,010Cash & Cash Equivalents
₩281,545,280Net Debt
2.94%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Pharmsville Co. Ltd. (ticker: 318010) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 27 employees. Market cap is $28.2B.

The current price is ₩3,560 with a P/E ratio of 9.77x and P/B of 0.42x.

ROE is 4.41% and operating margin is -5.29%. Annual revenue is $12.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Pharmsville Co. Ltd. (318010) Stock Forecast 2026 ₩3,560 — Price, Financials & Analyst Targets | Alpha Lenz